Literature DB >> 1279105

Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus.

S Sakuragi1, R Shibata, R Mukai, T Komatsu, M Fukasawa, H Sakai, J Sakuragi, M Kawamura, K Ibuki, M Hayami.   

Abstract

Two macaque monkeys were inoculated with a chimeric human and simian immunodeficiency virus carrying the tat, rev, vpu and env genes of human immunodeficiency virus type 1. Infectious virus was recovered from one of the monkeys at 2 and 6 weeks post-infection. The hybrid nature of the isolated viruses was verified by Southern and Western blotting analyses. Both of the monkeys infected with the chimera elicited a humoral antibody response against the virus.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1279105     DOI： 10.1099/0022-1317-73-11-2983

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  21 in total

1.  Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.

Authors:  S Himathongkham; N S Halpin; J Li; M W Stout; C J Miller; P A Luciw
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques.

Authors:  Tatsuhiko Igarashi; Ranjini Iyengar; Russel A Byrum; Alicia Buckler-White; Robin L Dewar; Charles E Buckler; H Clifford Lane; Kazuya Kamada; Akio Adachi; Malcolm A Martin
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

3.  Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques.

Authors:  Y Lu; P Brosio; M Lafaile; J Li; R G Collman; J Sodroski; C J Miller
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques.

Authors:  S V Joag; Z Li; L Foresman; E B Stephens; L J Zhao; I Adany; D M Pinson; H M McClure; O Narayan
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 5.  Use of broadly neutralizing antibodies for HIV-1 prevention.

Authors:  Amarendra Pegu; Ann J Hessell; John R Mascola; Nancy L Haigwood
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

6.  Persistent infection of macaques with simian-human immunodeficiency viruses.

Authors:  J T Li; M Halloran; C I Lord; A Watson; J Ranchalis; M Fung; N L Letvin; J G Sodroski
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Genetic complementation between replication-defective mutants of HIV-1 and SIVagm.

Authors:  T Miura; R Shibata; A Adachi; T Kuwata; J Chen; M Jin; E Ido; M Hayami
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 8.  Study human pancreatic cancer in mice: how close are they?

Authors:  Yuqing Zhang; Leon Chen; Jingxuan Yang; Jason B Fleming; Paul J Chiao; Craig D Logsdon; Min Li
Journal:  Biochim Biophys Acta       Date:  2012-11-09

9.  Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.

Authors:  C Lekutis; N L Letvin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Simian immunodeficiency virus DNA vaccine trial in macaques.

Authors:  S Lu; J Arthos; D C Montefiori; Y Yasutomi; K Manson; F Mustafa; E Johnson; J C Santoro; J Wissink; J I Mullins; J R Haynes; N L Letvin; M Wyand; H L Robinson
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.